Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) rose 0.8% during trading on Tuesday . The stock traded as high as GBX 8.12 ($0.10) and last traded at GBX 8.06 ($0.10). Approximately 249,014 shares were traded during trading, an increase of 82% from the average daily volume of 136,705 shares. The stock had previously closed at GBX 8 ($0.10).
Abingdon Health Price Performance
The stock has a market capitalization of £15.00 million, a PE ratio of -899.00 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The stock’s 50-day moving average is GBX 7.62 and its 200 day moving average is GBX 8.99.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
Read More
- Five stocks we like better than Abingdon Health
- What Are Growth Stocks and Investing in Them
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Stock Analyst Ratings and Canadian Analyst Ratings
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
